Health Catalyst
HCAT
198 hedge funds and large institutions have $2.68B invested in Health Catalyst in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 93 increasing their positions, 57 reducing their positions, and 22 closing their positions.
521% more call options, than puts
Call options by funds: $30.1M | Put options by funds: $4.85M
63% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 57
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
31% more capital invested
Capital invested by funds: $2.05B → $2.68B (+$629M)
7.07% more ownership
Funds ownership: 101.11% → 108.18% (+7.1%)
4% more funds holding
Funds holding: 190 → 198 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$106M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$96.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.3M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$14.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$25.5M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$23.2M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$11.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.2M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$11.1M |
HCAT Hedge Fund Activity: Q2 2021 in Review
198 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2021, worth a combined $2.68B — up 31% from $2.05B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new HCAT positions and 22 closed out — a net gain of 8 holders — while 93 added to existing stakes and 57 trimmed.
The largest buyer was BlackRock, adding an estimated $106M. The largest seller was Marshall Wace, exiting entirely with an estimated $25.5M sold.
- 198 institutional investors held Health Catalyst (HCAT) as of Q2 2021, up from 190 in Q1 2021.
- Funds reported $2.68B of Health Catalyst stock for Q2 2021, up 31% quarter-over-quarter.
- 30 funds opened new Health Catalyst positions in Q2 2021 and 22 closed out, a net change of +8 holders.
- The largest Health Catalyst buyer in Q2 2021 was BlackRock, an estimated $106M added.
- The largest Health Catalyst seller in Q2 2021 was Marshall Wace, an estimated $25.5M sold.
Based on aggregated 13F filings for Q2 2021.